Garnet Biotherapeutics Raises $10.4 Million
Garnet Biotherapeutics has raised $10.4 million in Series A funding. SCP Vitalife Partners led the round, and was joined by Safeguard Scientifics and Alliance Technology Ventures. The Malvern, Penn.-based company regenerative medicine company is focused on acclerating the healing and reducing the scarring associated with surgical procedures and other dermatologic conditions.
29 January 2009•4 mins read
